Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C17H21NO2.ClH |
Molecular Weight | 307.815 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CNCC[C@@H](OC1=C(OC)C=CC=C1)C2=CC=CC=C2
InChI
InChIKey=LCEURBZEQJZUPV-XFULWGLBSA-N
InChI=1S/C17H21NO2.ClH/c1-18-13-12-15(14-8-4-3-5-9-14)20-17-11-7-6-10-16(17)19-2;/h3-11,15,18H,12-13H2,1-2H3;1H/t15-;/m1./s1
Molecular Formula | C17H21NO2 |
Molecular Weight | 271.3541 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/16871320
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16871320
(R)-nisoxetine, an enantiomer of nisoxetine, is the potent and selective norepinephrine transporter (NET) inhibitor. Racemic nisoxetine doesn’t have any clinical application but had been researched as an antidepressant and its activity for NET resides mainly in the R-isomer.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P23975 Gene ID: 6530.0 Gene Symbol: SLC6A2 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/16871320 |
0.46 nM [Ki] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 00:41:46 GMT 2023
by
admin
on
Sat Dec 16 00:41:46 GMT 2023
|
Record UNII |
22NZ2QEN9S
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
22NZ2QEN9S
Created by
admin on Sat Dec 16 00:41:46 GMT 2023 , Edited by admin on Sat Dec 16 00:41:46 GMT 2023
|
PRIMARY | |||
|
114446-53-6
Created by
admin on Sat Dec 16 00:41:46 GMT 2023 , Edited by admin on Sat Dec 16 00:41:46 GMT 2023
|
PRIMARY | |||
|
12807463
Created by
admin on Sat Dec 16 00:41:46 GMT 2023 , Edited by admin on Sat Dec 16 00:41:46 GMT 2023
|
PRIMARY |